Suppr超能文献

特定的实验室检测方法能使列入肝移植名单的患者获得更高的终末期肝病模型(MELD)评分。

Specific laboratory methodologies achieve higher model for endstage liver disease (MELD) scores for patients listed for liver transplantation.

作者信息

Trotter James F, Brimhall Brad, Arjal Russ, Phillips Charles

机构信息

University of Colorado Health Sciences Center, Denver, CO 80262, USA.

出版信息

Liver Transpl. 2004 Aug;10(8):995-1000. doi: 10.1002/lt.20195.

Abstract

Priority for liver transplantation is currently based on the Model for Endstage Liver Disease (MELD) score, a mathematical function which includes the following objective variables: bilirubin, creatinine (Cr), and international normalized ratio (INR). We have noted that specific laboratory methodologies may yield consistently higher values of bilirubin, Cr, and INR. Therefore, we performed a study to determine if higher MELD scores could be obtained by utilizing laboratory methodologies selected to return higher laboratory values than standard methodologies used in our hospital's clinical laboratory. Phlebotomy was performed for routine clinical indications in 29 consecutive patients listed for liver transplantation. MELD scores were calculated using bilirubin, Cr, and INR from laboratory methods in our hospital's clinical laboratory (designated Lab #1) and from 2 other clinical laboratories (designated Lab #2 and Lab #3). The mean MELD score in our hospital's clinical laboratory (Lab #1) (13.6) was not significantly different than in Lab #2 (14.7), but in Lab #3, it was significantly higher by 20% (17.1), P <.03. Virtually all of the difference in MELD score between our hospital's clinical laboratory (Lab #1) and Lab #3 could be attributed to the INR, which was significantly higher by 26% in Lab #3 (1.9) vs. Lab #1 (1.4), P <.00002. Using MELD scores calculated from our hospital's clinical laboratory, the average change in priority for liver transplantation was from the 58th percentile to the 77th percentile (compared to Lab #3), P =.01. In conclusion, patients listed for liver transplantation at our center achieved significantly higher MELD scores and therefore a higher priority for liver transplantation by using laboratory methodologies that yield higher INR values than our hospital laboratory. The selection of laboratory methodologies may have a significant impact on MELD score.

摘要

目前,肝移植的优先级是基于终末期肝病模型(MELD)评分,这是一个数学函数,包含以下客观变量:胆红素、肌酐(Cr)和国际标准化比值(INR)。我们注意到,特定的实验室方法可能会使胆红素、Cr和INR的值持续偏高。因此,我们开展了一项研究,以确定采用某些实验室方法,使其得出的实验室值高于我院临床实验室所使用的标准方法得出的值,是否能获得更高的MELD评分。对连续29例等待肝移植的患者进行静脉穿刺采血以满足常规临床指征。使用我院临床实验室(标记为实验室1)以及另外2个临床实验室(标记为实验室2和实验室3)的实验室方法所测得的胆红素、Cr和INR来计算MELD评分。我院临床实验室(实验室1)的平均MELD评分为13.6,与实验室2(14.7)相比无显著差异,但在实验室3中,该评分显著高出20%,为17.1,P <.03。我院临床实验室(实验室1)与实验室3之间MELD评分的几乎所有差异都可归因于INR,实验室3(1.9)的INR值比实验室1(1.4)显著高出26%,P <.00002。使用我院临床实验室计算出的MELD评分,肝移植优先级的平均变化是从第58百分位升至第77百分位(与实验室3相比), P =.01。总之,在我们中心,等待肝移植的患者通过使用能得出比我院实验室更高INR值的实验室方法,获得了显著更高的MELD评分,从而在肝移植中获得了更高的优先级。实验室方法的选择可能会对MELD评分产生重大影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验